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Abstract 
Purpose The present study evaluated reproducibility of the inert gas rebreathing method to 
estimate cardiac output at rest and during cardiopulmonary exercise testing. 
Methods Thirteen healthy subjects (range 23-32 years) performed maximal graded 
cardiopulmonary exercise stress test using cycle ergometer on two occasions (Test 1 and Test 
2). Participants cycled at 30-watts/3-min increments until peak exercise. Haemodynamic 
variables were assessed at rest and during different exercise intensities (i.e. 60, 120, 150, 
180 watts) using inert gas rebreathing technique. 
Results Cardiac output and stroke volume were not significantly different between the two 
tests at rest 7.4 (1.6) vs. 7.1 (1.2) litre min-1, p=0.54; 114 (28) vs. 108 (15) ml beat-1, p=0.63) 
and all stages of exercise. There was a significant positive relationship between Test 1 and Test 
2 cardiac outputs when data obtained at rest and during exercise were combined (r=0.95, 
p<0.01 with coefficient of variation of 6.0%), at rest (r=0.90, p<0.01 with coefficient of 
variation of 5.1%), and during exercise (r=0.89, p<0.01 with coefficient of variation 3.3%). 
The mean difference and upper and lower limits of agreement between repeated measures of 
cardiac output at rest and peak exercise and were 0.4 (-1.1 to 1.8) litre min-1 and 0.5 (-2.3 to 
3.3) litre min-1 respectively. 
Conclusion Inert gas rebreathing method demonstrates acceptable level of test-retest 
reproducibility for estimating cardiac output at rest and during cardiopulmonary exercise 
testing at higher metabolic demands.  
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Introduction 
Cardiac output is an important parameters of the cardiovascular system function which 
provides an indication of systemic oxygen delivery and tissue perfusion. Changes in cardiac 
function are commonly reported in response to exercise training and pharmacological 
interventions [1]. Therefore, methods that can accurately detect haemodynamic changes in 
response to a clinical intervention are desirable. Cardiopulmonary exercise testing is 
recommended in evaluation of cardiorespiratory fitness and exercise tolerance in athletes, 
general population and patients [2–5]. Cardiac output measurement during stress testing helps 
define physiological adaptive mechanisms in response to an intervention. Additionally, it can 
improve risk stratification and management of patients with coronary artery disease, heart 
failure and those undergoing elective cardiac- and non-cardiac surgeries [5–8]. 
To date, there is no consensus on the best method for measuring cardiac output. In addition to 
being accurate, reproducible, safe, and easy to perform, new technologies in medicine should 
also be non-invasive. Currently available methods (i.e. pulse contour, oesophageal Doppler, 
carbon dioxide rebreathing, bioimpedance) rely on various assumptions and have limitations 
which restrict their routine use in medical practice [9–13].  Cardiac magnetic resonance 
imaging is currently accepted as the non-invasive gold standard method for cardiac output 
assessment [14, 15]. However, this technique is expensive, time consuming and not applicable 
in daily  practice [16].  
A non-invasive approach for cardiac output measurement at rest and during cardiopulmonary 
exercise stress testing is inert gas rebreathing (Innocor, Innovision, Denmark) [17]. In principle, 
it functions by measuring the rate of clearance of a physiologically inert gas from the 
pulmonary capillary circulation, which is directly proportional to pulmonary blood flow [18]. 
If the inert gas completely diffuses into the pulmonary capillary circulation (i.e. in the absence 
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of significant pulmonary shunt flow) pulmonary blood flow equals total cardiac output [16]. 
Previous studies have reported promising results for monitoring cardiac output using this 
method, when compared with the invasive gold standard thermodilution, [19, 20] and more 
recently, cardiac magnetic resonance imaging the non-invasive gold standard [15, 21] 
The two most important features of any clinical test are validity and reproducibility. A common 
method of assuring a reproducible response to cardiopulmonary exercise testing is to have the 
patient perform two exercise tests on separate days, at the same time of the day, and a test is 
considered reproducible if functional capacity of the cardiorespiratory system (i.e. peak oxygen 
uptake) is within 10% on both days [22]. 
Reproducibility of inert gas rebreathing method was subject to limited number of previous 
clinical investigations [17, 23]. However, these investigations have been focused on a 
reproducibility of measurements obtained in patients with limited functional capacity. To 
obtain a better insight into performance of the inert gas rebreathing method, ideally the study 
design will involve assessment of cardiac output at different levels of metabolic demand. 
Therefore, we designed the present study with the aim of assessing test-retest reproducibility 
of inert gas rebreathing method at rest and different stages of graded cardiopulmonary exercise 
testing in healthy volunteers.            
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Methods 
Participants 
Thirteen participants (10 males) who were non-smokers and free from cardiorespiratory, 
metabolic, and musculoskeletal diseases were enrolled into the study. The study protocol 
(number 15/NE/0190) was approved by local research Ethics Committee and all procedures 
were in accordance with the Declaration of Helsinki. All participants gave written informed 
consent. All aspects of the study were conducted at the Clinical Research Facility of the Royal 
Victoria Infirmary, Newcastle upon Tyne. Participants visited laboratory on two occasions (two 
days apart, Test 1 and Test 2) and were instructed to abstain from vigorous exercise 24h and 
from eating for at least 2h prior to each visit. Subjects were also instructed not to consume 
alcohol or caffeine containing foods and beverages on the test days. Upon arrival at the 
laboratory participants were asked to complete a standardised health screening questionnaire. 
This was followed by a 10-min rest period in supine position when blood pressure and ECG 
were measured. 
Study protocol and measurements 
Cardiac output, coupled with gas exchange metabolic and ventilatory data at rest and during 
exercise was recorded using the Innocor device (Innovision, Odense, Denmark) which uses 
inert gas rebreathing technique [17, 24] .  Exercise test was performed on an electro-
magnetically controlled semi-recumbent bicycle ergometer (Corival, Lode, Groningen, 
Netherlands). The test comprised three minutes rest period followed by a progressive exercise 
test of six steady-state stages each lasting 3 min (30, 60, 90, 120, 150 and 180 watts). 
Rebreathing maneuver and cardiac output recording were performed at rest and at 60, 120, 150 
and 180 watts. ECG and blood pressure were monitored throughout exercise using a 12-lead 
ECG using Custo Diagnostic system (SunTech Medical Inc. NC, USA). The test was 
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terminated when participants were unable to maintain a cadence of 60 – 70 revolutions per 
minute, or desired to stop. Peak exercise intensity was regarded as the maximum power output 
(watts) achieved before exercise was stopped. 
Inert gas rebreathing 
Inert gas rebreathing is based on the Fick’s principle and assumes that the rate of disappearance 
of a blood soluble gas from the alveoli is proportional to pulmonary blood flow in the absence 
of intrapulmonary shunt. The rebreathing system consists of a breathing valve attached to an 
online infrared photo-acoustic gas analyser which measured cardio-metabolic parameters in a 
closed system which contains a gas mixture of 0.5% nitrous oxide, N2O (blood-soluble gas), 
0.1% sulphur hexafluoride, SF6 (blood-insoluble gas) and 28% O2 in balanced Nitrogen in a 5 
L rubber bag. During rebreathing, the volume of blood soluble gas (N2O) in the alveoli 
decreases due to dissolution in blood, and the concentration of the insoluble gas decreases from 
the initial value in the bag to a final equilibrium value obtained after a few breaths. The Innocor 
software calculates cardiac output from the rate of uptake of expiratory (alveolar) N2O and is 
extrapolated from the gradient of logarithmically transformed N2O concentrations plotted 
against time. Stroke volume is calculated as the ratio between estimated cardiac output and 
measured heart rate. 
Data Analysis  
Data analyses were carried out using SPSS version 17.0 (SPSS Inc., Chicago, IL, USA). Data 
are expressed as mean (SD). Reproducibility of haemodynamic and metabolic variables were 
calculated using coefficient of variation (CV) while linear relationships between repeated 
measures were assessed using Pearson's correlation coefficient (r). CV was calculated as a 
percentage of within person S.D divided by within person average. A CV of ≤6% was 
considered as good reproducibility while CV of 6-10% and >10%  was considered acceptable 
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and poor reproducibility respectively [25]. Additionally, Bland-Altman plots were constructed 
to evaluate the upper and lower limits of agreements (± 2SD of mean difference) of cardiac 
output measured at rest and different intensities of exercise.[26] Cardiac output trending 
analysis was done using polar plot method as described by Critchley  and his colleagues [27].  
Results 
Physical characteristics of the subjects were: age 27 (23-32) years, weight 69.5 (9.7) kg, height 
171 (7) cm, body mass index 23.5 (2.2) kgm-2 and body surface area 1.8 (0.2) m2. All subjects 
completed each exercise test without any contraindication and a total of 46 paired rebreathing 
manoeuvres were performed. 
There was no significant difference in resting and exercise metabolic and ventilatory variables 
between Test 1 and Test 2 (Table 1). At rest and at all stages of exercise, there were no 
significant differences in cardiac output values between Test 1 and Test 2 (Figure 1). 
There were no significant differences between other haemodynamic variables (i.e. heart rate 
and stroke volume) at rest and during exercise between the two tests (Table 2). There was a 
strong relationship between Test 1 and Test 2 cardiac outputs when all data (rest and exercise) 
were combined together (r=0.95, p < 0.01 Figure 2). 
When all data were combined (rest and exercise), coefficient of variation for cardiac output, 
stroke volume and oxygen consumption were 6.0%, 11.1% and 5.7% respectively. Coefficients 
of correlations and variations for resting and each exercise stage haemodynamic data are 
presented in Table 2.     
Resting cardiac output (7.4 (1.5) vs 7.1 (1.1) litres min-1) and peak cardiac output 18.7 (3.6) vs 
18.2 (4.1) litres min-1) between both tests were not significantly different. The agreement 
between cardiac output estimates at Test 1 and Test 2 are shown using Bland-Altman analyses 
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(Figure 3A-D). Rest and peak exercise cardiac outputs between Test 1 and Test 2 showed mean 
difference and limits of agreement of 0.4 (-1.1 to 1.8 litres min-1, Figure 3B)  and 0.9 (-0.9 to 
2.6 litres min-1, Figure 3D). Further analysis including rest and exercise data together 
demonstrated a mean difference (limits of agreement) of 0.3 (-2.64 to 3.24 litres min-1, Figure 
3A), while the mean difference of low intensity (60 watts) and higher intensities (120-180 watts) 
were -0.1(-5.0 to 4.8 litres min-1) and 0.3 (-2.43-3.02 litres min-1, Figure 3C) respectively.  
Polar analysis after central exclusion showed a mean polar angle of 3 degrees, radial limits of 
agreement of less than 19○ and a concordance rate of 87%. Centrally occurring data was 
excluded when change in cardiac output was analysed. This was because small changes in 
cardiac output represent statistical noise which makes detection of true cardiac output changes 
difficult.  There was also a strong positive correlation between cardiac output and oxygen 
consumption for both tests (r > 0.91, P < 0.05) signifying that with increasing metabolic 
demand, there was increased ejection of blood to meet oxygen and nutritional demand of 
exercise muscles. However, only a moderate positive relationship was seen between peak 
exercise stoke volume and oxygen pulse although this was not significant (r= 0.49, p = 0.18)  
Discussion 
The present study assessed the test-retest reproducibility of resting and exercise hemodynamic 
and metabolic parameters in healthy individuals using inert gas rebreathing. The data show that 
inert gas rebreathing method demonstrates acceptable level of reproducibility in estimating 
cardiac output. Assessment of pulmonary blood flow and thus cardiac output from uptake of 
nitric oxide using inert gas rebreathing is safe and feasible. Reproducibility is usually assessed 
by performing two or more tests at different time intervals using a particular technique and 
maintaining similar testing conditions. A technique is assumed to be reproducible if the 
coefficient of variation of that test parameter was within 10% on repeated tests.[22] Limited 
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number of studies reported reproducibility of rebreathing methods for measuring cardiac output 
in clinical conditions [17, 23–25] and ours provides further evidence on reproducibility of inert 
gas rebreathing method using N2O as a test gas. In this study we reported acceptable 
reproducibility of inert gas rebreathing method in estimating cardiac output with mean CV of 
6.9% and 6.2% for rest and exercise measurements respectively. These data are consistent with 
previous studies which reported reproducibility of resting or peak exercise measurements in 
heart failure patients with a CV between 3.4% and 11% .[17, 20, 25]. At low exercise intensity 
i.e. 60 watts in the present study, reproducibility of cardiac output from inert gas rebreathing 
was poorer than at rest and higher exercise intensities (CV, 12.5%). This was possibly due to 
constant fluctuations in stroke volume which showed a high CV of 11.9% in response to onset 
of exercise whereas the heart rate remained fairly stable with a low CV of 3%.  Fontana et al., 
[28] noted that at exercise intensities below 70%  of an individual’s maximal capacity, there 
was a significant difference in repeated measures of stroke volume. They also suggested better 
volume reproducibility during higher exercise intensities. This may shed some insight on the 
use of inert gas rebreathing method for clinical cardiopulmonary exercise testing. Based on our 
current findings and those of Fontana et al. [28] it seems reasonable to suggest that the most 
reproducible cardiac output results using inert gas rebreathing methods can be obtained at high 
exercise intensities due to better reproducibility of the stroke volume component of cardiac 
output. Interpretation of inert gas rebreathing cardiac output data obtained at the beginning of 
cardiopulmonary exercise testing and low exercise intensities should be considered with 
caution when suggesting a potential effect of clinical interventions on cardiac function. This is 
clinically relevant as haemodynamic response to dynamic exercise especially at high intensities 
and peak exercise defines overall function and performance of the heart and can help explain 
the mechanisms underlying exercise intolerance. [29–31] 
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 The present results showed very good reproducibility of inert gas rebreathing method with 
increased metabolic demand. When cardiac output was analysed at peak exercise, 
reproducibility was even better with coefficient of variation of 3.3%. At rest and at low 
intensity exercise, it is possible that not all parts of the lungs are perfused and also ventilated. 
This means there is incomplete mixing of gases and possibly pulmonary shunt that may result 
in slight variation of cardiac output values as previously suggested. [32] As exercise intensity 
increases, increase in lung volume and pulmonary blood flow progresses, thereby leading to 
adequate mixing and uptake of rebreathing gases. [33]. Our peak exercise cardiac output result 
thus corroborates the notion that rebreathing methods are more accurate for monitoring cardiac 
output during increased metabolic demand and higher exercise intensities. [34]. Although there 
is a paucity of data on reproducibility of inert gas rebreathing during different exercise 
intensities, our findings are in agreement with one previous study conducted in patients with 
heart failure demonstrating low CV and acceptable reproducibility [25]. Only one study [17] 
has investigated the reproducibility of cardiac output measured by inert gas rebreathing at rest 
and during different stages of graded exercise. Unlike the present study which showed better 
reproducibility as exercise intensity increased, Agostoni et al. reported a CV ranging between 
9 and 11% for all exercise intensities. However, testing was done in heart failure patients 
It has been previously suggested that resting cardiac output values in healthy adults may range 
between 5 and 8 l/min. Similar values as ours have previously been reported by Fontana et al. 
[28] and Reutershan et al. [23]. It is possible that the rebreathing technique may require 
increased metabolic demand and consequently slightly increased values of cardiac output at 
rest, as previously suggested [35]. This may be due to the increased breathing frequency 
required, which increases oxygen demand from respiratory muscles and in turn increases 
cardiac output. [24]. Other studies have reported an underestimation of cardiac output by N2O 
rebreathing technique compared to other techniques at rest and during exercise [36, 37] with 
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over  > 30% of recorded values lower than what was considered possible [37]. This is possibly 
due to recirculation of N2O [38] which could reduce the alveolar-arterial diffusion gradient for 
N2O and attenuate further N2O uptake [39] 
Similarly, data presented here show good reproducibility of metabolic variables at rest and 
exercise. Metabolic parameters showed very good reproducibility throughout exercise. 
Reproducibility of peak oxygen consumption per body weight was 3.7%, which is similar to 
previous studies using non-invasive gas exchange measurement systems. [25, 40] Bland- 
Altman analysis for both cardiac output and metabolic data show low mean differences 
between Test 1 and Test 2 and acceptable limits of agreement. Although Bland-Altman analysis 
has been used extensively to show agreement between comparative cardiac output 
measurements, it has been criticised as it does not provide useful standard parameter such as 
percentage error for which the quality of repeated measurement could be based upon. [41] 
Therefore to verify results from coefficients of variation and Bland-Altmans analyses and also 
ascertain cardiac output trending capability, polar plots were constructed. Results showed mean 
polar angle of 3 degrees, radial limits of agreement of 19○ and a concordance rate of 87%. These 
results are significant as Critchley and colleagues [41] note that for good trending to occur, 
mean polar angle or angular bias must be less than ±5○, radial limits of agreement should be 
within ±30○ and a concordance rate of 95%. Therefore, it is reasonable to suggest that inert gas 
rebreathing shows acceptable cardiac output trending. The concordance rate in the present 
study was lower than expected perhaps due to 30 data points used in analysis after central data 
exclusion.  
The current study is not without limitation. Firstly, relatively small sample size of healthy 
volunteers can potentially reduce generalisation of the study findings. However, by collecting 
data at rest and during different levels of exercise intensity provide sufficient data points for 
study to adequately assess reproducibility between repeated measures. Secondly, the feature of 
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the rebreathing method is that it requires a subject to ‘learn how to perform rebreathing 
manoeuvre’ i.e. a learning effect. Detailed explanation and familiarisation with the rebreathing 
procedures was carried out with each study participants resulting in a valid rebreathing 
manoeuvre being performed. Thirdly, there might have been sampling bias as the study 
comprised three minutes rest period followed by a progressive exercise test of four steady-state 
stages each lasting 3 min, meaning that intensity and time into 
the experiment were correlated.  
Conclusion 
The findings of the present study suggest that inert gas rebreathing method demonstrates 
acceptable test-retest reproducibility in measuring cardiac output at rest and at submaximal to 
peak levels of metabolic demand during cardiopulmonary exercise stress testing. The present 
study encourages integration of non-invasive cardiac output monitoring in cardiopulmonary 
exercise stress testing procedures as cardiac and metabolic data generated during higher 
intensity and peak exercise could help improve understanding of exercise intolerance. Future 
prospective studies are warranted to define clinical (i.e. diagnostic and prognostic) and cost-
effectiveness of non-invasive gas rebreathing cardiac output assessment.         
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Table 1 Reproducibility of metabolic measurements at rest and peak exercise. 
Variables Test 1 Test 2 P value r CV (%) 
Rest  
VO2 (litre min-1) 0.3 (0.1) 0.3 (0.1) 0.86 0.43 15.9 
VO2 (ml kg-1min-1) 4.4 (1.7) 4.7 (1.6) 0.69 0.65 15.3 
VCO2 (litre min-1) 0.3 (0.1) 0.3 (0.1) 0.83 0.44 17.3 
VE (litre min-1) 10.9 (3.3) 10.9 (2.9) 0.97 0.64 15.4 
RER 0.8 (0.1) 0.8 (0.1) 0.65 0.32 4.5 
SPO2 (%) 97 (1) 98 (1) 0.20 0.52 0.4 
Oxygen pulse (ml beat-1) 4.5 (1.7) 5.0 (1.7) 0.41 0.73 14.0 
Peak Exercise 
VO2 (litre min-1) 2.2 (0.5) 2.2 (0.5) 0.88 0.60 8.9 
VO2 (mlkg-1min-1) 32.5 (6.7) 32.9 (6.2) 0.84 0.95 3.7 
VCO2 (litre min-1) 2.3 (0.6) 2.3 (0.4) 0.79 0.38 10.9 
VE (litre min-1)  62 (14) 57 (16) 0.43 0.75 9.8 
RER 1.0  (0.1) 1.0 (0.1) 0.26 0.85 3.1 
SPO2 (%) 95 (3) 97 (2) 0.26 0.60 0.9 
Oxygen pulse (ml beat-1) 19.3 (6.3) 18.6 (6.0) 0.79 0.84 3.2 
VE- minute ventilation, VO2- Oxygen consumption, SPO2- peripheral oxygen saturation, RER- 
respiratory exchange ratio VCO2- carbon dioxide release. Data are expressed as mean (SD) 
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Table 2 Reproducibility of haemodynamic measurements at rest and different exercise intensities.  
Variables Test 1 Test 2 P  r CV (%) 
Rest 
CO (litre min-1) 7.4 (1.6) 7.1 (1.2) 0.54 0.90 6.9 
HR (beats min-1) 65 (7) 68 (10) 0.72 0.85 4.9 
SV (ml beat-1) 114 (28) 108 (15) 0.63 0.61 13 
VO2 (ml kg-1 min-1) 4.4 (1.7) 4.7 (1.6) 0.69 0.65 15.3 
60 watts 
CO (litre min-1) 11.5 (1.9) 11.6 (2.6) 0.92 0.49 12.5 
HR (beats min-1) 99 (10) 99 (8) 0.96 0.83 3 
SV (ml beat-1) 122.3 (34.2) 122.1 (32.4) 0.99 0.45 11.9 
VO2 (ml kg-1min-1) 14.3 (1.6) 13.7 (1.9) 0.59 0.65 7.9 
120 watts 
CO (litre min-1) 15.0 (3) 14.4 (3) 0.68 0.87 6.3 
HR (beats min-1) 138 (20) 138 (19) 0.99 0.96 1.9 
SV (ml beat-1) 132 (44) 134 (38) 0.94 0.85 5.9 
VO2 (ml kg-1min-1) 23.4 (4) 25 (5) 0.47 0.92 5.3 
150 watts 
CO (litre min-1) 17.2 (4) 17.3 (4) 0.81 0.77 4.3 
HR (beats min-1) 145 (19) 147 (23) 0.88 0.98 2.3 
SV (ml beat-1) 126 (35) 123 (43) 0.89 0.86 5.1 
VO2 (ml kg-1min-1) 27 (4) 26 (5) 0.76 0.83 5.6 
180 watts 
CO (litre min-1) 20.4 (2.3) 19.8 (2.6) 0.49 0.92 3.8 
HR (beats min-1) 163 (15) 160 (17) 0.86 0.99 1.4 
SV (ml beat-1) 135 (25) 132 (25) 0.89 0.92 4.8 
VO2 (ml kg-1min-1) 35 (1.7) 33.4 (0.9) 0.15 0.75 3.4 
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CO - cardiac output, HR - Heart Rate, SV - Stroke Volume, VO2 - Oxygen Consumption, r: 
correlation coefficient, CV - coefficient of variation. Data are expressed as mean (SD) 
 
 
Figure 1. Mean cardiac output at rest and at different stages of exercise on two tests 
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Figure 2. Relationship between cardiac output estimates obtained at Test 1 and Test 2 when 
taken together (rest and exercise data).  
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Figure 3. Bland-Altman plots to demonstrate limits of agreement between Test 1 and Test 2 
at rest and exercise (combined data, A); at rest (B); high intensities (120-180watts, C); and at 
peak exercise (D). The solid line represents the mean difference and the dashed lines 
represent lower and upper limits of agreement between Test 1 and Test 2. 
 
 
